Amgen Inc. sell Bank of America Co.
Start price
26.09.25
/
50%
€231.00
Target price
26.09.26
€233.10
Performance (%)
18.24%
Price
12.12.25
€270.75
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 18.24%. A total of €2.38 was paid as dividends for this prediction. This prediction currently runs until 26.09.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | -4.430% | -4.430% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Bank of America Corporation from $261.00 to $272.00. They now have an "underperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat